NasdaqCM - Delayed Quote USD

Trevena, Inc. (TRVN)

0.4090 +0.0280 (+7.35%)
At close: April 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,207.0000
-418.0000
567.0000
3,069.0000
Cost of Revenue
616.0000
3,018.0000
954.0000
182.0000
Gross Profit
2,591.0000
-3,436.0000
-387.0000
2,887.0000
Operating Expense
37,079.0000
52,939.0000
51,538.0000
32,372.0000
Operating Income
-34,488.0000
-56,375.0000
-51,925.0000
-29,485.0000
Net Non Operating Interest Income Expense
-1,114.0000
-805.0000
161.0000
211.0000
Other Income Expense
5,136.0000
3,510.0000
176.0000
205.0000
Pretax Income
-30,466.0000
-53,670.0000
-51,588.0000
-29,069.0000
Tax Provision
--
--
--
300.0000
Net Income Common Stockholders
-30,738.0000
-53,670.0000
-51,588.0000
-29,369.0000
Diluted NI Available to Com Stockholders
-30,738.0000
-53,670.0000
-51,588.0000
-29,369.0000
Basic EPS
-2.65
-7.59
-7.90
-5.75
Diluted EPS
-2.65
-7.59
-7.90
-5.75
Basic Average Shares
10,850.6980
7,072.3620
6,529.0740
5,104.9540
Diluted Average Shares
10,850.6980
7,072.3620
6,529.0740
5,104.9540
Total Operating Income as Reported
-34,488.0000
-56,375.0000
-51,925.0000
-29,485.0000
Total Expenses
37,695.0000
55,957.0000
52,492.0000
32,554.0000
Net Income from Continuing & Discontinued Operation
-30,766.0000
-53,670.0000
-51,588.0000
-29,369.0000
Normalized Income
-43,639.0000
-64,861.0000
-51,592.0000
-29,368.2700
Interest Income
1,194.0000
451.0000
162.0000
240.0000
Interest Expense
2,308.0000
1,256.0000
1.0000
29.0000
Net Interest Income
-1,114.0000
-805.0000
161.0000
211.0000
EBIT
-28,158.0000
-52,414.0000
-51,587.0000
-29,040.0000
EBITDA
-27,827.0000
-52,032.0000
-51,159.0000
-28,563.0000
Reconciled Cost of Revenue
616.0000
3,018.0000
954.0000
182.0000
Reconciled Depreciation
331.0000
382.0000
428.0000
477.0000
Net Income from Continuing Operation Net Minority Interest
-30,766.0000
-53,670.0000
-51,588.0000
-29,369.0000
Total Unusual Items Excluding Goodwill
12,873.0000
11,191.0000
4.0000
-1.0000
Total Unusual Items
12,873.0000
11,191.0000
4.0000
-1.0000
Normalized EBITDA
-40,700.0000
-63,223.0000
-51,163.0000
-28,562.0000
Tax Rate for Calcs
--
--
--
0.0003
Tax Effect of Unusual Items
--
--
--
-0.2700
12/31/2020 - 1/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TOVX Theriva Biologics, Inc.
0.4100
+11.22%
 
IMNN Imunon, Inc.
1.4400
+10.77%
 
KA Kineta, Inc.
0.6398
+3.19%
 
LPCN Lipocine Inc.
4.5500
+2.48%
 
NBY NovaBay Pharmaceuticals, Inc.
0.0770
-0.39%
 
ASLN ASLAN Pharmaceuticals Limited
0.4480
-4.68%
 
KPRX Kiora Pharmaceuticals, Inc.
0.4800
-5.10%
 
CLNN Clene Inc.
0.3465
+2.82%
 
FNCH Finch Therapeutics Group, Inc.
2.2400
-2.18%
 
VAXX Vaxxinity, Inc.
0.1214
-8.45%